Search Results - Issei Saeki

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma

    Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma by Issei Saeki, Naoki Yamamoto, Takahiro Yamasaki, Taro Takami, Masaki Maeda, Koichi Fujisawa, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Koichi Uchida, Kenji Tani, Isao Sakaida

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma

    Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma by Yurika Kotoh, Yutaka Suehiro, Issei Saeki, Tomomi Hoshida, Masaki Maeda, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Yoshitaro Shindo, Yukio Tokumitsu, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment

    Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment by Issei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, Tadasuke Hanazono, Yohei Urata, Takakazu Furutani, Yuichiro Yokoyama, Toshiyuki Oishi, Masaki Maeda, Teruaki Kimura, Yurika Kotoh, Ryo Sasaki, Takashi Miyaji, Takashi Oono, Yuki Aibe, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-... by Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki, Toru Ishikawa, Yoshitaka Inaba, Naoki Morimoto, Hiroshi Aikata, Nobukazu Tanabe, Yoshiyuki Wada, Yasuteru Kondo, Masahiro Tsuda, Kazuhiko Nakao, Takanori Ito, Tetsuya Hosaka, Yusuke Kawamura, Teiji Kuzuya, Shunsuke Nojiri, Chikara Ogawa, Hironori Koga, Keisuke Hino, Masafumi Ikeda, Michihisa Moriguchi, Takashi Hisai, Kenichi Yoshimura, Junji Furuse, Yasuaki Arai

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice

    Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice by Shigeo Shimose, Issei Saeki, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Satoru Kakizaki, Takeshi Hatanaka, Kyo Sasaki, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Soji Nishina, Motoyuki Otsuka, Hiroki Kawashima, Tetsuji Takayama, Taro Takami, Takumi Kawaguchi

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy

    Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy by Issei Saeki, Shigeo Shimose, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Satoru Kakizaki, Takeshi Hatanaka, Kyo Sasaki, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Yuki Kanayama, Atsushi Naganuma, Sohji Nishina, Motoyuki Otsuka, Hideki Kobara, Hiroki Kawashima, Tetsuji Takayama, Takumi Kawaguchi, Takahiro Yamasaki, Taro Takami

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

    Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients by Masaki Maeda, Issei Saeki, Isao Sakaida, Hiroshi Aikata, Yasuyuki Araki, Chikara Ogawa, Kazuya Kariyama, Kazuhiro Nouso, Mikiya Kitamoto, Haruhiko Kobashi, Shuichi Sato, Hiroshi Shibata, Kouji Joko, Shintaro Takaki, Hiroyuki Takabatake, Akemi Tsutsui, Koichi Takaguchi, Tetsu Tomonari, Shinichiro Nakamura, Takakazu Nagahara, Atsushi Hiraoka, Tomomitsu Matono, Masahiko Koda, Mari Mandai, Tomohiko Mannami, Akeri Mitsuda, Takashi Moriya, Kazuhisa Yabushita, Joji Tani, Takahito Yagi, Takahiro Yamasaki

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: